GoodRx Holdings, Inc. GDRX Marketing and selling
Marketing and selling at other companies
Other financials
Where this comes from
Reported directly by GoodRx Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedMarketingCostsCurrent.
The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about GoodRx Holdings, Inc.'s marketing and selling.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is GoodRx Holdings, Inc.'s marketing and selling?
- GoodRx Holdings, Inc. (GDRX) reported marketing and selling of $17.24M in Q1 2026.
- How has GoodRx Holdings, Inc.'s marketing and selling changed year-over-year?
- GoodRx Holdings, Inc.'s marketing and selling increased by 67.9% year-over-year, from $10.27M to $17.24M.
- What is the long-term trend for GoodRx Holdings, Inc.'s marketing and selling?
- Over 3 years (2022 to 2025), GoodRx Holdings, Inc.'s marketing and selling has grown at a -3.0% compound annual growth rate (CAGR), from $12.1M to $11.06M.